Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
InfoPack
Recent JCP Articles on InfoPack
JCP
InfoPack
Emerging Treatments in Schizophrenia
February 15, 2022
Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
InfoPack
Improving Outcomes in Patients With Bipolar Depression: A Comprehensive Review
March 25, 2015
Andrew A. Nierenberg
,
Gary S. Sachs
,
Roger S. McIntyre
JCP
InfoPack
Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes
August 26, 2014
Mark Olfson
,
John M. Kane
,
Christoph U. Correll
, et al
Recent PCC Articles on InfoPack
PCC
Case Report
Medical and Cultural Approach to OCD
June 23, 2026
This case demonstrates successful management of severe religious OCD through medication optimization and psychotherapy over an 18-month treatment period.
Tirth Patel
,
Shady S. Shebak
PCC
Rounds in the General Hospital
Medical Complications of Psychedelics
June 23, 2026
This case-based review covers acute complications, drug interactions, and long-term safety across psilocybin, MDMA, ketamine, and ibogaine, with practical guidance for clinicians.
Franklin King IV
,
Brian S. Barnett
,
S. Trevor Taylor
, et al
JCP
Commentary
The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context
June 22, 2026
The authors discuss the findings of a recent study by Rahamim et al.
Eric Bui
,
Naomi M. Simon
Featured
InfoPack Research
JCP
Original Research
Posttrauma Benzodiazepine Use and Subsequent PTSD
June 22, 2026
In this naturalistic setting of mass trauma, short-term benzodiazepine use during 30 days postexposure was not associated with increased PTSD risk at 12 months.
Ofer Rahamim
,
Aviv Segev
,
Dana Sinai
PCC
Original Research
Primary Users of the VA Health Care System
June 18, 2026
This study examined the sociodemographic and clinical profiles of veterans who primarily rely on the VA health care system for care, revealing a particularly vulnerable group who tend to...
Sarah Meshberg-Cohen
,
Shelby R. Goodwin
,
Ian C. Fischer
, et al
PCC
Case Report
Visual Snow Syndrome and Bupropion
June 18, 2026
A patient in their 60s with advanced macular degeneration complicated by bilateral geographic atrophy presented with new-onset visual disturbances shortly after initiation of bupropion for depression.
Dax C. Volle